# Statseal® for Central Venous Catheter Insertion Sites in Critical Care

> **NCT06451185** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Liverpool Heart and Chest Hospital NHS Foundation Trust** · enrollment: 450 (estimated)

## Conditions studied

- Central Line
- Central Venous Catheter
- Vascular Access
- Critical Care
- Hemostatic

## Interventions

- **OTHER:** A haemostatic mineral powder product.

## Key facts

- **NCT ID:** NCT06451185
- **Lead sponsor:** Liverpool Heart and Chest Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-14
- **Primary completion:** 2025-09-19
- **Final completion:** 2025-11-30
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06451185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06451185, "Statseal® for Central Venous Catheter Insertion Sites in Critical Care". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06451185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*